56 results match your criteria: "MS4 Research Institute[Affiliation]"
IBRO Neurosci Rep
June 2024
Leiden University, Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden, the Netherlands.
Purpose: To investigate longitudinal relationships between employment status and disease-related, (neuro)psychological, and work-related factors in people with multiple sclerosis (MS).
Methods: 170 employed people with MS underwent yearly neurological and neuropsychological examinations to assess MS-related disability and cognitive functioning. Additionally, they completed yearly questionnaires assessing depression, anxiety, fatigue, cognitive complaints, workplace support and coping.
Interact J Med Res
July 2023
MS4 Research Institute, Nijmegen, Netherlands.
The impact of information and communication technology (ICT) on medicine is unprecedented and ever-increasing. This has made it more and more difficult for doctors to keep pace with ICT developments and to adequately match the input of ICT experts. As a result, medical disciplines may not be able to take full advantage of growing possibilities.
View Article and Find Full Text PDFDegener Neurol Neuromuscul Dis
June 2023
Department of Clinical Psychological Science, Faculty of Psychology and Neurosciences, Maastricht University, Maastricht, 6229 ER, the Netherlands.
Purpose: Sexual motives are major determinants of sexual behaviour. It has been known that sexual motives may vary according to circumstances. Multiple sclerosis (MS) is a chronic disease causing a broad range of symptoms and disabilities, that often interfere with sexual activities.
View Article and Find Full Text PDFMult Scler J Exp Transl Clin
December 2022
Department of Care Ethics, University of Humanistic Studies, Utrecht, The Netherlands.
Previous research discovered a protective effect of higher conscientiousness against a 3-year deterioration in employment status in persons with multiple sclerosis (pwMS). To replicate these findings, we used data from a multicentre prospective cohort study where 145 employed pwMS completed questionnaires, neurological and neuropsychological examinations at baseline and after 3 years. A 3-year deterioration in employment status was reported in 31.
View Article and Find Full Text PDFIBRO Neurosci Rep
December 2022
Leiden University, Institute of Psychology, Health, Medical and Neuropsychology Unit, Leiden, the Netherlands.
Background: Unemployment is common among people with multiple sclerosis (pwMS) and has been associated with subjective cognitive difficulties, specifically in memory, attention, and executive functioning. However, longitudinal research on subjective cognitive difficulties and employment is scarce.
Objective: We investigated whether subjective cognitive impairment (SCI), based on the clinical cut-off score of the MS Neuropsychological Screening Questionnaire (MSNQ), was associated with work status and negative work events (NWE) at baseline and after 2 years.
BMC Neurol
November 2022
Multiple Sclerosis Center, Department of Neurology, Isala Hospital, Zwolle, the Netherlands.
Background: We designed a new multi-modal version of the MSmonitor, called the MSmonitor-Plus and Video calling Care (MPVC), a self-management and education program with e-health interventions that combines frequent use of specific questionnaires with video calling in treating multiple sclerosis (MS) patients.
Objective: To assess the effectiveness, cost-effectiveness and feasibility of MPVC compared to care as usual (CAU), with the goal of achieving equal or better quality of life for MS patients and their partners/informal caregivers. Our hypothesis is that by using MPVC, monitoring will become more efficient, that patients' self-efficacy, quality of life, and adherence to treatment will improve, and that they will be able to live their lives more autonomously.
Int J Mol Sci
September 2022
Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
Multiple sclerosis (MS) is a degenerative disease of the central nervous system in which auto-immunity-induced demyelination occurs. MS is thought to be caused by a complex interplay of environmental and genetic risk factors. While most genetic studies have focused on identifying common genetic variants for MS through genome-wide association studies, the objective of the present study was to identify rare genetic variants contributing to MS susceptibility.
View Article and Find Full Text PDFMult Scler J Exp Transl Clin
September 2022
Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
Background: Symptoms of anxiety and depression affect the daily life of people with multiple sclerosis (MS). This study examined work difficulties and their relationship with anxiety, depression and coping style in people with MS.
Methods: 219 employed people with MS (median age = 43 years, 79% female) completed questionnaires on anxiety, depression, coping style, demographics and work difficulties, and underwent a neurological examination.
JMIR Form Res
November 2021
Department of Community & Occupational Medicine, University Medical Centre Groningen, Groningen, Netherlands.
Background: Walking disturbances are a common dysfunction in persons with multiple sclerosis (MS). The 2-Minute Walking Test (2MWT) is widely used to quantify walking speed. We implemented a smartphone-based 2MWT (s2MWT) in MS sherpa, an app for persons with MS.
View Article and Find Full Text PDFDisabil Rehabil
November 2022
Institute of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.
Purpose: This study aimed to identify mental health, physical health, demographic and disease characteristics relating to work productivity in people with multiple sclerosis (MS).
Methods: In this cross-sectional study, 236 employed people with MS (median age = 42 years, 78.8% female) underwent neurological and neuropsychological assessments.
J Neurol Sci
August 2021
University of Humanistic Studies, Utrecht, the Netherlands; Elisabeth-TweeSteden Hospital, Department of Neurology, Tilburg, the Netherlands.
Background: Multiple sclerosis (MS) poses a major threat to sustainable employability. Identifying conditions and factors that promote work participation is of great importance. Our objective was to explore the contribution of personality traits in explaining occupational functioning in MS.
View Article and Find Full Text PDFBMC Med Inform Decis Mak
April 2021
Department of Health Services Research, School CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Background: Since decision making about treatment with disease-modifying drugs (DMDs) for multiple sclerosis (MS) is preference sensitive, shared decision making between patient and healthcare professional should take place. Patient decision aids could support this shared decision making process by providing information about the disease and the treatment options, to elicit the patient's preference and to support patients and healthcare professionals in discussing these preferences and matching them with a treatment. Therefore, a prototype of a patient decision aid for MS patients in the Netherlands-based on the principles of multi-criteria decision analysis (MCDA) -was developed, following the recommendations of the International Patient Decision Aid Standards.
View Article and Find Full Text PDFNutr Neurosci
August 2022
Department of Neurology, St. Elisabeth-Tweesteden Hospital, Tilburg, Netherlands.
Background: A healthy diet has been associated with less symptoms or progression of disease in multiple sclerosis (MS). However, whether specific diets are needed, or general healthy diet recommendations are sufficient is unknown.
Objective: To investigate the association between diet quality, use of diets, and quality of life (QoL) in men and women with MS.
Med Decis Making
November 2020
School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Background: Up to 31% of patients with relapsing-remitting multiple sclerosis (RRMS) discontinue treatment with disease-modifying drug (DMD) within the first year, and of the patients who do continue, about 40% are nonadherent. Shared decision making may decrease nonadherence and discontinuation rates, but evidence in the context of RRMS is limited. Shared decision making may, however, come at additional costs.
View Article and Find Full Text PDFJMIR Mhealth Uhealth
October 2020
Department of Community & Occupational Medicine, University Medical Centre Groningen, Groningen, Netherlands.
Background: The decline of cognitive processing speed (CPS) is a common dysfunction in persons with multiple sclerosis (MS). The Symbol Digit Modalities Test (SDMT) is widely used to formally quantify CPS. We implemented a variant of the SDMT in MS sherpa, a smartphone app for persons with MS.
View Article and Find Full Text PDFMult Scler Relat Disord
June 2020
Department of Neurology, Elisabeth-TweeSteden Hospital, PO Box 90151, 5000 LC, Tilburg, the Netherlands; Department of Care Ethics, University of Humanistic Studies, PO Box 797, 3500 AT, Utrecht, the Netherlands. Electronic address:
Background: Recent studies report deficits in social cognition in individuals with multiple sclerosis (MS). Social cognitive skills such as empathy are important for adequate social and occupational functioning. Our objectives are: (1) to examine whether empathy differs between individuals with MS and healthy controls, (2) to examine relations between empathy and cognitive, psychological and occupational functioning.
View Article and Find Full Text PDFJ Med Internet Res
March 2020
Isala Hospital, Meppel, Netherlands.
Background: Empowerment helps persons with a chronic disease to self-manage their condition and increase their autonomy and participation. MSmonitor (Curavista bv) is an interactive Web-based program for self-management and multidisciplinary care in multiple sclerosis (MS). It includes, among others, short questionnaires on fatigue (Modified Fatigue Impact Scale-5 [MFIS-5]) and health-related quality of life (HRQoL, Leeds Multiple Sclerosis Quality of Life [LMSQoL]); long questionnaires on disabilities, perception of disabilities (Multiple Sclerosis Impact Profile), and HRQoL (Multiple Sclerosis Quality of Life-54); a Medication and Adherence Inventory and an Activity Diary.
View Article and Find Full Text PDFDisabil Rehabil
June 2021
National Multiple Sclerosis Foundation, Rotterdam, The Netherlands.
Purpose: The current study aimed to evaluate the psychometric properties of the Dutch version of the Multiple Sclerosis Work Difficulties Questionnaire-23 (MSWDQ-23).
Methods: Two hundred and thirty-nine employed persons with multiple sclerosis (MS) and 59 healthy controls completed the MSWDQ-23. To verify the factor structure, a confirmatory factor analysis was conducted.
PLoS One
March 2020
Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
In patients with chronic disorders, control self-efficacy is the confidence with managing symptoms and coping with the demands of illness. Can do treatment (CDT) is an intensive, 3-day, social cognitive theory-based, multidisciplinary treatment that focuses on identification of stressors, goal setting, exploration of boundaries, and establishment of new boundaries. An uncontrolled study showed that patients with relapsing remitting multiple sclerosis (RRMS) and low-disability had improved control self-efficacy six months after CDT.
View Article and Find Full Text PDFMult Scler Relat Disord
October 2019
University Medical Centre Groningen, Department of Community and Occupational Medicine, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands; MS4 Research Institute, Nijmegen, the Netherlands. Electronic address:
Observational studies investigate a wide range of topics in multiple sclerosis research. This paper presents an overview of the various observational designs and their applications in clinical studies. Observational studies are well suited for making discoveries and assessing new explanations of phenomena, but less so for establishing causal relationships, due to confounding by indication (selection bias), co-morbidity, socio-economic or other factors.
View Article and Find Full Text PDFNeurol Sci
December 2019
Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, PO Box 9555, 2300 RB, Leiden, The Netherlands.
Background: Cognitive functioning has been linked to employment outcomes in multiple sclerosis (MS) in cross-sectional studies. Longitudinal studies are however lacking and previous studies did not extensively examine executive functioning.
Objectives: We examined whether baseline cognitive functioning predicts a change in employment status after 2 years, while taking into account mood, fatigue and disability level.
J Med Econ
October 2019
Department of Community & Occupational Medicine, University Medical Centre Groningen, Groningen , The Netherlands.
This trial-based economic evaluation (EE) assesses from a societal perspective the cost-effectiveness of an intensive 3-day cognitive theory-based intervention (CDT), compared to care-as-usual, in patients with relapsing remitting multiple sclerosis (RRMS) and low disability (Expanded Disability Status Scale [EDDS] score < 4.0). The trial of the EE was registered in the Dutch Trial Register: Trial NL5158 (NTR5298).
View Article and Find Full Text PDFMult Scler Relat Disord
June 2019
Department of Neurology, Elisabeth-TweeSteden Hospital, PO Box 90151, 5000 LC Tilburg, the Netherlands; Department of Care Ethics, University of Humanistic Studies, PO Box 797, 3500 AT Utrecht, the Netherlands. Electronic address:
Background: Multiple sclerosis (MS) is a chronic disorder of the central nervous system with an unpredictable disease course. Life partners often become caregivers, which can be both rewarding and challenging, as the caregiver's physical and mental health is often negatively affected. Previous studies on caregiver strain focused on caregivers of persons with MS with relatively high disability levels, while caregiver strain may already be experienced by life partners living with mildly disabled persons with MS.
View Article and Find Full Text PDFPLoS One
April 2019
Institut für Neuroimmunologie und Multiple Sklerose, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Background: Adequate disease and treatment-related risk knowledge of people with Multiple Sclerosis (pwMS) is a prerequisite for informed choices in medical encounters. Previous work showed that MS risk knowledge is low among pwMS and role preferences are different in Italy and Germany.
Objective: We investigated the level of risk knowledge and role preferences in 8 countries and assessed putative variables associated with risk knowledge.
Health Qual Life Outcomes
June 2018
National Multiple Sclerosis Foundation, Mathenesserlaan 378, Rotterdam, 3023 HB, The Netherlands.
Background: The aim of this study was to examine whether work capabilities differ between workers with Multiple Sclerosis (MS) and workers from the general population. The second aim was to investigate whether the capability set was related to work and health outcomes.
Methods: A total of 163 workers with MS from the MS@Work study and 163 workers from the general population were matched for gender, age, educational level and working hours.